Home | News | Find a Doctor | Ask a Question | Free

More EGRF inhibition evidence


Abnormal Hair Growth in a Patient With Head and Neck Cancer Treated With the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab


But it can work even the other way around:

Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib